A mechanism of resistance to BET inhibitors in AML cells suggested by Rather et al. consists of the acquisition of BRD4 independence to drive MYC transcription trough the suppression of PRC2 complex activity [102]. Here, BRD4 is linked to acute myeloid leukemia.